Aimmune Therapeutics Inc (NASDAQ:AIMT) saw a large increase in short interest during the month of May. As of May 15th, there was short interest totalling 17,620,000 shares, an increase of 6.5% from the April 30th total of 16,550,000 shares. Currently, 39.4% of the company’s shares are short sold. Based on an average daily volume of […]
